NCT06233617View on ClinicalTrials.gov

Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Spine Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

March 1, 2025

Study Completion Date

April 1, 2025

Conditions
Spinal FusionSpine DiseaseSpinal StenosisErector Spinae Plane Block
Interventions
DRUG

0.9% Sodium Chloride Injection

biliteral administration of 20ml of 0,2% ropivacaine + 2ml 0.9% sodium chloride for the erector spine plane block

DRUG

Dexamethasone 4 Mg/mL Injectable Solution

biliteral administration of 20ml of 0,2% ropivacaine with 4mg Dexamethasone for the erector spine plane block

DRUG

Dexmedetomidine injection

biliteral administration of 20ml of 0,2% ropivacaine with 50ug Dexmedetomidine for the erector spine plane block

Trial Locations (1)

61-701

RECRUITING

Poznan University of Medical Sciences, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER